RUNX1 and acute myeloid leukemia: RUNX1 is a recurrent target of somatic mutations in de novo AML, myelodysplastic syndrome (MDS), acute lymphocytic leukemia (ALL), atypical chronic myeloid leukemia (aCML), and secondary AML (Mangan and Speck, 2011).